BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

26 related articles for article (PubMed ID: 1284543)

  • 1. Novel cystic fibrosis mutation associated with mild disease in Cypriot patients.
    Boteva K; Papageorgiou E; Georgiou C; Angastiniotis M; Middleton LT; Constantinou-Deltas CD
    Hum Genet; 1994 May; 93(5):529-32. PubMed ID: 7513296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cystic fibrosis patients with mutation 1949del84 in exon 13 of the CFTR gene have a similar clinical severity as delta F508 homozygotes.
    Nunes V; Casals T; Gaona A; Antiñolo G; Ferrer-Calvete J; Pérez-Frias J; Tardío E; Molano J; Estivill X
    Hum Mutat; 1992; 1(5):375-9. PubMed ID: 1284539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of a novel nonsense mutation (L88X) in exon 3 of the cystic fibrosis transmembrane conductance regulator gene in a native Korean cystic fibrosis chromosome.
    Macek M; Hamosh A; Kiesewetter S; McIntosh I; Rosenstein BJ; Cutting GR
    Hum Mutat; 1992; 1(6):501-2. PubMed ID: 1284542
    [No Abstract]   [Full Text] [Related]  

  • 4. Age of the delta F508 cystic fibrosis mutation.
    Kaplan NL; Lewis PO; Weir BS
    Nat Genet; 1994 Nov; 8(3):216-8. PubMed ID: 7533028
    [No Abstract]   [Full Text] [Related]  

  • 5. Identification of a CFTR frameshift mutation (1013 delAA) in trans to delta F508 in a pancreatic sufficient cystic fibrosis patient.
    Nasr SZ; Strong TV; Collins FS
    Hum Mol Genet; 1994 Nov; 3(11):2063-4. PubMed ID: 7533026
    [No Abstract]   [Full Text] [Related]  

  • 6. Mutation analysis and haplotype correlation for 139 cystic fibrosis patients from the Nebraska Regional Cystic Fibrosis Center.
    Traystman MD; Schulte N; Colombo JL; Sammut PH; Reilly P; Patel C; Acquazzino D; Simanek B; Anderson R; Kimberling WJ
    Hum Mutat; 1993; 2(1):7-15. PubMed ID: 7682884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. delta F508 cystic fibrosis mutation appears very infrequently in the Greek-Cypriot community of Cyprus.
    Constantinou-Deltas CD; Georgiou C; Ioannou P; Angastiniotis M; Aristodemou E
    Hum Mutat; 1992; 1(6):503-5. PubMed ID: 1284543
    [No Abstract]   [Full Text] [Related]  

  • 8. Dysfunction of CFTR bearing the delta F508 mutation.
    Welsh MJ; Denning GM; Ostedgaard LS; Anderson MP
    J Cell Sci Suppl; 1993; 17():235-9. PubMed ID: 7511616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reverse genetics and cystic fibrosis.
    Iannuzzi MC; Collins FS
    Am J Respir Cell Mol Biol; 1990 Apr; 2(4):309-16. PubMed ID: 1691007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The spectrum of cystic fibrosis mutations.
    Tsui LC
    Trends Genet; 1992 Nov; 8(11):392-8. PubMed ID: 1279852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cystic fibrosis mice have arrived!
    Higgins CF; Trezise AE
    Hum Mol Genet; 1992 Oct; 1(7):459-60. PubMed ID: 1284887
    [No Abstract]   [Full Text] [Related]  

  • 12. A primer of current molecular genetic strategies for clinicians.
    Hooper PF; Dreesen TD
    Arch Otolaryngol Head Neck Surg; 1993 Oct; 119(10):1085-94. PubMed ID: 7691091
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.